Last reviewed · How we verify

A Multi-component Intervention to Improve Medication Adherence in People With Depressive Disorders (MAPDep)

NCT03668457 NA COMPLETED

Objective: The study of medication adherence in depression (MAPDep study) aims to evaluate the effectiveness and cost-effectiveness of a multi-component strategy to enhance patient-centered care to improve adherence toward medications in patients with depression, formed by an educational intervention to psychiatrists and/or a collaborative care intervention group to patients and relatives plus a reminder system through the use of a mobile APP. Methods: The objective will be assessed under an open multicenter, clinical controlled trial with random allocation by clusters to one of three interventions or to usual care (control arm). In group 1 only patients and family members receive intervention, in group 2 only psychiatrists receive intervention, and group 3 is a combined intervention for patients and psychiatrists. The main measure will be the change in medication adherence rate. Secondary endpoints are depression, emotional distress, health-related quality of life, physical functioning, patients' knowledge about their medications, provider beliefs regarding patient-centeredness, and healthcare resource utilization.

Details

Lead sponsorServicio Canario de Salud
PhaseNA
StatusCOMPLETED
Enrolment170
Start dateSun Mar 01 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
CompletionTue Nov 01 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

Interventions

Countries

Spain